Profile data is unavailable for this security.
About the company
Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.
- Revenue in BRL (TTM)6.47bn
- Net income in BRL423.76m
- Incorporated1964
- Employees27.30k
- LocationFleury SAAv. General Valdomiro de Lima508, JabaquaraSAO PAULO 04.344-070BrazilBRA
- Phone+55 1 150351986
- Fax+55 1 150147425
- Websitehttps://www.fleury.com.br/
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 12.62m | 2.31% |
| APG Asset Management NVas of 31 Dec 2022 | 7.31m | 1.34% |
| Goldman Sachs Asset Management LPas of 31 Jan 2024 | 6.93m | 1.27% |
| Kapitalo Investimentos Ltda.as of 31 Dec 2023 | 6.60m | 1.21% |
| Bram Bradesco Asset Management S/A DTVMas of 31 Dec 2023 | 6.60m | 1.21% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 04 Apr 2024 | 4.94m | 0.90% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 4.83m | 0.88% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 4.27m | 0.78% |
| Funda��o dos Economi�rios Federais FUNCEFas of 31 Dec 2023 | 3.70m | 0.68% |
| Lemanik Asset Management SAas of 30 Jun 2023 | 3.66m | 0.67% |
